EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

RETRACTION: Zinc Oxide Nanoparticle Inhibits Tumorigenesis of Renal Cell Carcinoma by Modulating Lipid Metabolism Targeting miR‐454‐3p to Repressing Metabolism Enzyme ACSL4

Journal Of Oncology

Journal of Oncology · 2026-01 · 2026 (1)

DOI: 10.1155/jo/9820480 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Oncology, online erschienen am 03.11.2026. Verfasst von Journal Of Oncology. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Oncology, J. O. (2026). RETRACTION: Zinc Oxide Nanoparticle Inhibits Tumorigenesis of Renal Cell Carcinoma by Modulating Lipid Metabolism Targeting miR‐454‐3p to Repressing Metabolism Enzyme ACSL4. Journal of Oncology, 2026(1). https://doi.org/10.1155/jo/9820480

Vancouver

Oncology JO. RETRACTION: Zinc Oxide Nanoparticle Inhibits Tumorigenesis of Renal Cell Carcinoma by Modulating Lipid Metabolism Targeting miR‐454‐3p to Repressing Metabolism Enzyme ACSL4. Journal of Oncology. 2026;2026(1). doi:10.1155/jo/9820480

BibTeX
@article{Oncology2026,
  author = {Oncology, Journal Of},
  title = {RETRACTION: Zinc Oxide Nanoparticle Inhibits Tumorigenesis of Renal Cell Carcinoma by Modulating Lipid Metabolism Targeting miR‐454‐3p to Repressing Metabolism Enzyme ACSL4},
  journal = {Journal of Oncology},
  year = {2026},
  volume = {2026},
  number = {1},
  doi = {10.1155/jo/9820480}
}
Kostenlos starten →